@article{f1bdd902922b49aa86792670e9dcdd1b,
title = "Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): A randomised open-label controlled trial",
author = "Yves Reznik and Ohad Cohen and Ronnie Aronson and Ignacio Conget and Sarah Runzis and Javier Castaneda and Lee, {Scott W.}",
note = "Funding Information: The study was sponsored by Medtronic International Trading S{\`a}rl, Tolochenaz, Switzerland. We thank the OpT2mise study team at Medtronic for their support; and the monitors, investigators, study coordinators, and patients for having done this trial. We also thank Simona de Portu, John Shin, and Severine Liabat (employees of Medtronic), for their assistance throughout the conduct of the study. Medical writing and editorial assistance in the preparation of this paper, funded by Medtronic, was provided by Dr Michael Shaw (MScript, Hove, UK). ",
year = "2014",
doi = "10.1016/S0140-6736(14)61037-0",
language = "English",
volume = "384",
pages = "1265--1272",
journal = "The Lancet",
issn = "0140-6736",
number = "9950",
}